Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
61 participants
INTERVENTIONAL
2011-06-30
2013-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Low Grade Inflammation in Childhood Obesity : an Independent Risk Factor for Endothelial Dysfunction
NCT04181398
Obesity, Physical Inactivity or Dietary Fat ?
NCT00434265
Lifestyle, Adiposity and Cardiovascular Health in Youths
NCT00006402
The Role of Atrial Natriuretic Peptide in the Lipolytic Process: Effect of Obesity and Exercise
NCT02418728
Obesity, Inflammation and Aging: Effects of Physical Exercise and Omega-3 Fatty Acids.
NCT03300388
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Particularly, the following aims are set forth:
1. To establish the effect of a combined lifestyle intervention, i.e. an individualized exercise training and caloric restriction program, on vascular function (primary endpoint) and structure in a substantial population of obese adolescents.
2. To characterize causal pathways between obesity and endothelial dysfunction with focus on classical risk factors, oxidative and inflammatory stress, metabolic adaptations, bone marrow derived progenitor cells, and blood microparticles.
This research knowledge will be instrumental for risk stratification and clinical management aimed to improve endothelial function by limiting damage and reinforcing regenerative mechanisms in obese adolescents.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise training
Individualized and progressively increased supervised aerobic exercise program on a daily base (3-4hours per day, hypocaloric diet and psychological guidance
Exercise training
Individualized and progressively increased supervised aerobic exercise program on a daily base (3-4hours per day, hypocaloric diet and psychological guidance
Usual Care
Nutritional assessment and dietary advice by general practitioner, promotion of sports activities
Usual care
Nutritional assessment and dietary advice by general practitioner, promotion of sports activities
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise training
Individualized and progressively increased supervised aerobic exercise program on a daily base (3-4hours per day, hypocaloric diet and psychological guidance
Usual care
Nutritional assessment and dietary advice by general practitioner, promotion of sports activities
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Older than 16 yrs: BMI ≥35 kg/m²
Exclusion Criteria
* Structural heart disease or other cardiac diseases.
* Active malignant hematological disease
12 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zeepreventorium
OTHER
University Hospital, Antwerp
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Luc Bruyndonckx
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Viviane M Conraads, M.D., PhD
Role: PRINCIPAL_INVESTIGATOR
Dienst Cardiale Revalidatie, Cardiologie, Universitair Ziekenhuis Antwerpen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zeepreventorium
De Haan, , Belgium
Dienst Cardiale Revalidatie, Cardiologie, Universitair Ziekenhuis Antwerpen
Edegem, , Belgium
Dienst Pediatrie, Universitair Ziekenhuis Antwerpen
Edegem, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EC 11/11/100
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.